30 May 2024
30 May 2024
The acquisition is intended to enhance Merck’s ophthalmology portfolio.
The speed and flexibility required in clinical trials for COVID-19 set a new precedent for what can be achieved in fighting infectious diseases. From collaborative digital platforms to utilizing AI, GlobalData examines some of the key trends affecting contract research organizations (CROs).
TD patients can experience symptom improvement within two weeks of starting AUSTEDO XR.
The European Commission approved BMS’ Opdivo combination therapy for urothelial cancer based on Phase III data.
The US FDA has set an action date of 27 November for the combination therapy of Roche’s inavolisib, Pfizer’s Ibrance, and fulvestrant.
Vabysmo gained FDA approval in January 2022 in the wet age-related macular degeneration and diabetic macular oedema spaces.
The gene therapy candidate is designed to treat plakophilin-2 related arrhythmogenic cardiomyopathy.
The initiative bolsters Africa's preparedness for future epidemic and pandemic threats.
GlobalData’s AI governance framework helps senior executives identify all potential risks posed by AI systems and provides a checklist of questions to ask tech vendors during the procurement process to ensure they implement AI responsibly.
GlobalData’s AI governance framework helps senior executives identify all potential risks posed by AI systems and provides a checklist of questions to ask tech vendors during the procurement process to ensure they implement AI responsibly.
GlobalData’s AI governance framework helps senior executives identify all potential risks posed by AI systems and provides a checklist of questions to ask tech vendors during the procurement process to ensure they implement AI responsibly.
GlobalData’s AI governance framework helps senior executives identify all potential risks posed by AI systems and provides a checklist of questions to ask tech vendors during the procurement process to ensure they implement AI responsibly.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
